Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics, Inc.

Overview
Date Founded

2004

Headquarters

131 Hartwell Avenue,Suite 320,Lexington, MA 02421

Type of Company

Public

Employees (Worldwide)

11

Industries

Biotechnology
Pharmaceuticals
Hospitals & Patient Services

Company Description

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Contact Data
Trying to get in touch with decision makers at Aldeyra Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer, President & Director

Chief Financial Officer & Principal Accounting Officer

Chief Commercial Officer

Chief Development Officer

Co-Founder

Member, Anterior Segment Scientific Advisory Board

Senior Vice President of Clinical Development

Board of Directors

Former Senior Vice President-Corporate Development at Genzyme Corp.

Co-Founder at Nexeption LLC

Former Executive Chairman at Envisia Therapeutics, Inc.

Chief Executive Officer, President & Director at Aldeyra Therapeutics, Inc.

Former Senior Vice President-Global Human Health Business Development at Schering-Plough Corporation

Co-Founder at Peptimmune, Inc.

Executive Officer at Ascendance Biotechnology, Inc.

Paths to Aldeyra Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Aldeyra Therapeutics, Inc.
Owners & Shareholders
Details Hidden

Founded in 1999, Perceptive Advisors focuses on supporting progress in the life sciences industry by identifying opportunities and directing financial resources toward the most promising technologies in modern healthcare. Today, the firm manages approximately $7.3 billion across our strategies.

Details Hidden

Avidity Partners Management LP (APM) is a hedge fund manager headquartered in Dallas, Texas founded by Michael David Gregory. APM provides investment advice.

Details Hidden

MS is an active growth-oriented investor and manages portfolios invested in global equity with a long-term outlook. The firm focuses on mid- and small-cap companies from the healthcare sector, including pharma, emerging pharma, biotech, genomics, medtech, drug delivery and e-health.MS uses computer models to continuously screen a selection of 700-800 listed companies as well as pre-IPOs for which they systematically collect data in a proprietary database. This information is completed by both in-house and third-party fundamental research

Recent Transactions
Details Hidden

Aldeyra Therapeutics, Inc. issued . USD Common Stock

Details Hidden

Aldeyra Therapeutics, Inc. purchases Helio Vision, Inc.

Details Hidden

Aldeyra Therapeutics, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Transaction Advisors
Auditor

Advised onAldeyra Therapeutics, Inc. issued . USD Common Stock

Escrow Agent

Advised onAldeyra Therapeutics, Inc. issued . USD Common Stock

Legal Advisor

Advised onAldeyra Therapeutics, Inc. issued . USD Common Stock

Legal Advisor

Advised onAldeyra Therapeutics, Inc. issued . USD Common Stock

Founding Partner

Advised onAldeyra Therapeutics, Inc. issued . USD Common Stock

Associate

Advised onAldeyra Therapeutics, Inc. issued . USD Common Stock

Advisors & Consultants
Consultant

Chief Medical Officer at Allena Pharmaceuticals, Inc.

Consultant

Chief Financial Officer & Principal Accounting Officer at Stoke Therapeutics, Inc.

Publicist

Managing Director at Westwicke Partners LLC

Key Stats and Financials As of 2020
Market Capitalization
$538M
Total Enterprise Value
$195M
Earnings Per Share
$-1.11
Revenue
$0
Net Profit
$-37.6M
EBITDA
$-34.6M
TEVNet Income
-5.21x
Debt TEV
0.08x
Total Equity
$59.5M
Total Debt
$15.3M
Investors
Details Hidden

Johnson & Johnson Innovation JJDC, Inc. is a venture capital arm of Johnson & Johnson (NYSE: JNJ) located in US. The firm targets companies sectors such as pharmaceuticals, medical devices and consumer healthcare services. They provide financing for all stages, from seed-level startups to Series B and beyond.

Details Hidden

Co-Founder at Aldeyra Therapeutics, Inc.

Details Hidden

Vice President-Corporate Communications & Investor Relations at Flexion Therapeutics, Inc.

Suppliers
Ligand Pharmaceuticals, Inc. Medical Support Services | La Jolla, CA

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Madrigal Pharmaceuticals, Inc. Pharmaceuticals | West Conshohocken, PA

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.

Massachusetts Eye & Ear Infirmary, Inc. Medical Support Services | Boston, MA

Massachusetts Eye & Ear Infirmary operates as hospital that provides patient care for disorders of the eye, ear, nose, throat, head and neck. It offers ophthalmology and otolaryngology research services and is a teaching partner of Harvard Medical School. The firm’s programs and services include anesthesiology, ophthalmology, otolaryngology, radiology, Coolidge Clinic laboratory and libraries. The company was founded in 1824 and is headquartered in Boston, MA.

Competitors
Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Amgen, Inc. Biotechnology - Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Aldeyra Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Aldeyra Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Aldeyra Therapeutics, Inc..